INVO Fertility, Inc. (NASDAQ:IVF) saw its stock price leap 13% following news that the company received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for a new patent ...

INVO Bioscience (NASDAQ:INVO) just reported results for the second quarter of 2024. INVO Bioscience reported earnings per share of -62 cents. The company reported revenue of $1.84 million.

About INVO Fertility We are a healthcare services fertility company dedicated to expanding assisted reproductive technology (”ART”) care to patients in need.